TY - JOUR
T1 - Foundational Science and Mechanistic Insights for a Shared Disease Model
T2 - An Expert Consensus
AU - Developed by the AUGS Basic Science Subcommittee and IUGA Special Interest Group
AU - Alperin, Marianna
AU - Abramowitch, Steven
AU - Alarab, May
AU - Bortolini, Maria
AU - Brown, Bryan
AU - Burnett, Lindsey A.
AU - Connell, Kathleen A.
AU - Damaser, Margot S.
AU - de Vita, Raffaella
AU - Gargett, Caroline E.
AU - Guess, Marsha K.
AU - Guler, Zeliha
AU - Jorge, Renato Natal
AU - Kelley, Robert S.
AU - Kibschull, Mark
AU - Miller, Kristin
AU - Moalli, Pamela A.
AU - Mysorekar, Indira U.
AU - Routzong, Megan R.
AU - Shynlova, Oksana
AU - Swenson, Carolyn W.
AU - Therriault, Marrisa A.
AU - Northington, Gina M.
N1 - Publisher Copyright:
© 2022 American Urogynecologic Society and International Urogynecological Association. All rights reserved.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - Pelvic floor disorders (PFDs) are complex conditions that impact millions of women worldwide. It is estimated that PFDs will affect approximately 30%–50% of women older than 50 years and incur a 20% lifetime risk of undergoing at least 1 surgical procedure to repair either pelvic organ prolapse (POP) or stress urinary incontinence (SUI) by age 80 years.1 The surgical costs alone are estimated to exceed $10 billion annually,1–6 and this does not account for the cost of nonsurgical and conservative treatments. Although a large body of epidemiological literature provides important information regarding the risk factors for PFDs, the pathogenesis of POP and SUI continues to be poorly understood. Consequently, POP and SUI are associated with significant health care expenditure primarily due to lack of preventive measures, high failure rate of available interventions, and the need for retreatments. Furthermore, the long-standing gaps in mechanistic insights into the pathophysiology of POP and SUI represent one of the major barriers to the development of scientifically rational preventive and therapeutic strategies. Women's health across the life span depends on a better understanding of the anatomy and physiology of the female pelvic floor (PF) and the causal links between the multifactorial epidemiological risk factors and POP/SUI.
AB - Pelvic floor disorders (PFDs) are complex conditions that impact millions of women worldwide. It is estimated that PFDs will affect approximately 30%–50% of women older than 50 years and incur a 20% lifetime risk of undergoing at least 1 surgical procedure to repair either pelvic organ prolapse (POP) or stress urinary incontinence (SUI) by age 80 years.1 The surgical costs alone are estimated to exceed $10 billion annually,1–6 and this does not account for the cost of nonsurgical and conservative treatments. Although a large body of epidemiological literature provides important information regarding the risk factors for PFDs, the pathogenesis of POP and SUI continues to be poorly understood. Consequently, POP and SUI are associated with significant health care expenditure primarily due to lack of preventive measures, high failure rate of available interventions, and the need for retreatments. Furthermore, the long-standing gaps in mechanistic insights into the pathophysiology of POP and SUI represent one of the major barriers to the development of scientifically rational preventive and therapeutic strategies. Women's health across the life span depends on a better understanding of the anatomy and physiology of the female pelvic floor (PF) and the causal links between the multifactorial epidemiological risk factors and POP/SUI.
KW - aging
KW - biomechanics of the female pelvic floor
KW - impact of hormonal milieu on the female pelvic floor structure and function
KW - pelvic floor disorders
KW - pelvic floor structural anatomy and mechanism of disease
KW - pelvic organ prolapse
KW - stress urinary incontinence
UR - http://www.scopus.com/inward/record.url?scp=85132456072&partnerID=8YFLogxK
U2 - 10.1097/SPV.0000000000001216
DO - 10.1097/SPV.0000000000001216
M3 - Article
C2 - 35609252
AN - SCOPUS:85132456072
SN - 2151-8378
VL - 28
SP - 347
EP - 350
JO - Female Pelvic Medicine and Reconstructive Surgery
JF - Female Pelvic Medicine and Reconstructive Surgery
IS - 6
ER -